Atherosclerosis
What's New
Last Posted: Feb 08, 2024
- Association of Clinical Characteristics With Familial Hypercholesterolaemia Variants in a Lipid Clinic Setting: A Case-Control Study.
Bobby V Li et al. J Lipid Atheroscler 2024 13(1) 29-40 - Familial Hypercholesterolemia Variant and Cardiovascular Risk in Individuals With Elevated Cholesterol.
Yiyi Zhang et al. JAMA Cardiol 2024 - International Atherosclerosis Society Roadmap for Familial Hypercholesterolaemia.
Gerald F Watts et al. Glob Heart 2024 19(1) 12 - Artificial Intelligence in Coronary Artery Calcium Scoring Detection and Quantification.
Khaled Abdelrahman et al. Diagnostics (Basel) 2024 14(2) - Assessment of ethnic inequalities in diagnostic coding of familial hypercholesterolaemia (FH): A cross-sectional database study in Lambeth, South London.
Mariam Molokhia et al. Atherosclerosis 2023 388117353 - A generalizable electrocardiogram-based artificial intelligence model for 10-year heart failure risk prediction.
Liam Butler et al. Cardiovasc Digit Health J 2024 4(6) 183-190 - Metabolic syndrome prediction using non-invasive and dietary parameters based on a support vector machine.
Sahar Mohseni-Takalloo et al. Nutr Metab Cardiovasc Dis 2023 - Novel Finnish-enriched variants causing severe hypercholesterolemia and their clinical impact on coronary artery disease.
Nella Junna et al. Atherosclerosis 2023 117327 - Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults.
João Albuquerque et al. Atherosclerosis 2023 383117314 - Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia.
Tomáš Šálek et al. Biochem Med (Zagreb) 2023 33(3) 030705 - Concordance of a High Lipoprotein(a) Concentration Among Relatives.
Laurens F Reeskamp et al. JAMA Cardiol 2023 - Development and Multinational Validation of a Novel Algorithmic Strategy for High Lp(a) Screening.
Arya Aminorroaya et al. medRxiv 2023 - Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium.
Marc Snel et al. Acta Cardiol 2023 1-8 - Premature atherosclerosis: An analysis over 39 years in the Netherlands. Implications for young individuals in high-risk families.
Juliette Crooijmans et al. Atherosclerosis 2023 117267 - A linear weighted combination of polygenic scores for a broad range of traits improves prediction of coronary heart disease.
Kristjan Norland et al. Eur J Hum Genet 2023 - Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.
Manuela Casula et al. Atherosclerosis 2023 117231 - Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group.
Cristina Pederiva et al. Nutrients 2023 15(15) - Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini Review.
Corey Snyder et al. Interv Cardiol (Lond) 2023 15(Suppl 17) 433-437 - Early-Life Adversity Associations With Later Life Epigenetic Aging Profiles in the Multi-Ethnic Study of Atherosclerosis.
Lauren L Schmitz et al. Am J Epidemiol 2023 8 - Contemporary Polygenic Scores of Low-Density Lipoprotein Cholesterol and Coronary Artery Disease Predict Coronary Atherosclerosis in Adolescents and Young Adults.
Rodrigo Guarischi-Sousa et al. Circ Genom Precis Med 2023 7 e004047 - Prevalence of hypercholesterolaemia in outpatient children aged 9-11 years.
Nour Ibrahim et al. Ann Med Surg (Lond) 2023 85(6) 2564-2567 - International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia.
Gerald F Watts et al. Nat Rev Cardiol 2023 - Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS).
Alan Jones et al. Atherosclerosis 2023 37567-74 - Development and validation of explainable machine-learning models for carotid atherosclerosis early screening.
Ke Yun et al. J Transl Med 2023 21(1) 353 - Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
Poranee Ganokroj et al. J Atheroscler Thromb 2023 - Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events
SS Khan et al, JAMA Network Open, May 23, 2023 - The contribution of the exposome to the burden of cardiovascular disease.
Thomas Münzel et al. Nat Rev Cardiol 2023 - 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Marina Cuchel et al. Eur Heart J 2023 - Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study.
Berit Storgaard Hedegaard et al. Atherosclerosis 37310-16 - LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis.
M M Schreuder et al. Atherosclerosis
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 27, 2024
- Content source: